share_log

eFFECTOR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M

eFFECTOR Therapeutics | 4:持股变动声明-董事 Loewy Caroline M

SEC announcement ·  02/21 17:42
Moomoo AI 已提取核心信息
Caroline M. Loewy, associated with eFFECTOR Therapeutics, Inc. (EFTR), has engaged in a transaction involving the company's stock. The action took place on February 19, 2024. However, the details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares after the action have not been disclosed. The relationship of Caroline M. Loewy to the issuer was not specified in the announcement.
Caroline M. Loewy, associated with eFFECTOR Therapeutics, Inc. (EFTR), has engaged in a transaction involving the company's stock. The action took place on February 19, 2024. However, the details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares after the action have not been disclosed. The relationship of Caroline M. Loewy to the issuer was not specified in the announcement.
与Effector Therapeutics, Inc.(EFTR)有联系的卡罗琳·洛维参与了一项涉及该公司股票的交易。该行动发生在 2024 年 2 月 19 日。但是,有关所涉股票数量、股票性质、交易价格和行动后股票总价值的细节尚未披露。公告中没有具体说明卡罗琳·洛维与发行人的关系。
与Effector Therapeutics, Inc.(EFTR)有联系的卡罗琳·洛维参与了一项涉及该公司股票的交易。该行动发生在 2024 年 2 月 19 日。但是,有关所涉股票数量、股票性质、交易价格和行动后股票总价值的细节尚未披露。公告中没有具体说明卡罗琳·洛维与发行人的关系。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息